Back to SL SIH Partners, LLLP

TSHA

2 quarters

Position history for SLSIH Partners, LLLP's holdings in Taysha Gene Therapies, Inc.

No. SIH Partners exited its TSHA (Taysha Gene Therapies) position in Q2 2025. Its Q1 2025 13F listed 12,173 shares worth $16,920. SIH Partners first reported TSHA in Q1 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$16,920

Total Shares Change

-12,173

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$2.31
0
2025-Q1
New
12,173
-
$16,9200.0%$1.39
25

Other major holders of TSHA: Avoro Capital Advisors LLC, RA Capital Management, L.P., Goldman Sachs Group Inc., FMR LLC

Optional analytics helps us improve. How it’s used